Peripheral blood biomarkers in multiple sclerosis

Antonella D'Ambrosio, Simona Pontecorvo, Tania Colasanti, Silvia Zamboni, Ada Francia, Paola Margutti

Research output: Contribution to journalArticlepeer-review


Multiple sclerosis is the most common autoimmune disorder affecting the central nervous system. The heterogeneity of pathophysiological processes in MS contributes to the highly variable course of the disease and unpredictable response to therapies. The major focus of the research on MS is the identification of biomarkers in biological fluids, such as cerebrospinal fluid or blood, to guide patient management reliably. Because of the difficulties in obtaining spinal fluid samples and the necessity for lumbar puncture to make a diagnosis has reduced, the research of blood-based biomarkers may provide increasingly important tools for clinical practice. However, currently there are no clearly established MS blood-based biomarkers. The availability of reliable biomarkers could radically alter the management of MS at critical phases of the disease spectrum, allowing for intervention strategies that may prevent evolution to long-term neurological disability. This article provides an overview of this research field and focuses on recent advances in blood-based biomarker research.

Original languageEnglish
Pages (from-to)1097-1110
Number of pages14
JournalAutoimmunity Reviews
Issue number12
Publication statusPublished - Dec 1 2015


  • Autoimmune disease
  • Biomarkers
  • Multiple sclerosis
  • Therapy

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy


Dive into the research topics of 'Peripheral blood biomarkers in multiple sclerosis'. Together they form a unique fingerprint.

Cite this